Geneesmiddelenbeleid

This motion concerns the national pharmaceutical policy in the Netherlands. It aims to address the strategic approach to the development, procurement, and distribution of medicines to ensure sustainable healthcare and patient access to necessary treatments. This procedure primarily affects the healthcare sector, pharmaceutical companies, and patients within the Netherlands by potentially altering how medicines are managed and funded.